Milestone drug approvals failed to boost Biogen’s growth. BIIB Shares rose early Friday as analysts analyzed Thursday’s actions …
Tag:
Biogens
-
-
Food and Drug Administration on Tuesday first drug approved For a rare genetic form of neuropathic ALS, despite …